Shervin Rabizadeh

5.3k total citations · 2 hit papers
53 papers, 3.3k citations indexed

About

Shervin Rabizadeh is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Shervin Rabizadeh has authored 53 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Genetics, 22 papers in Epidemiology and 14 papers in Surgery. Recurrent topics in Shervin Rabizadeh's work include Inflammatory Bowel Disease (25 papers), Microscopic Colitis (20 papers) and Eosinophilic Esophagitis (6 papers). Shervin Rabizadeh is often cited by papers focused on Inflammatory Bowel Disease (25 papers), Microscopic Colitis (20 papers) and Eosinophilic Esophagitis (6 papers). Shervin Rabizadeh collaborates with scholars based in United States, Canada and Netherlands. Shervin Rabizadeh's co-authors include Cynthia L. Sears, David L. Huso, Shaoguang Wu, Ki‐Jong Rhee, Xinqun Wu, Franck Housseau, Drew M. Pardoll, Emilia Albesiano, Frederick L. Brancati and Florencia McAllister and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Shervin Rabizadeh

50 papers receiving 3.2k citations

Hit Papers

A human colonic commensal... 2009 2026 2014 2020 2009 2011 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shervin Rabizadeh United States 21 1.7k 815 786 722 687 53 3.3k
Joshua M. Uronis United States 15 2.9k 1.7× 490 0.6× 939 1.2× 1.0k 1.4× 327 0.5× 23 4.0k
Hafid O. Al‐Hassi United Kingdom 26 900 0.5× 652 0.8× 572 0.7× 776 1.1× 406 0.6× 68 2.9k
Dirk Seegert Germany 24 1.1k 0.7× 670 0.8× 731 0.9× 1.3k 1.8× 594 0.9× 31 3.3k
Keston Aquino-Michaels United States 7 2.5k 1.5× 873 1.1× 1.5k 1.9× 664 0.9× 226 0.3× 11 4.1k
Hendrik M. van Dullemen Netherlands 30 994 0.6× 1.5k 1.9× 960 1.2× 663 0.9× 1.1k 1.6× 79 4.2k
Martina E. Spehlmann Germany 18 1.1k 0.6× 987 1.2× 231 0.3× 699 1.0× 623 0.9× 45 2.5k
Ray Jupp United Kingdom 18 1.7k 1.0× 342 0.4× 391 0.5× 825 1.1× 570 0.8× 22 2.9k
Hirotsugu Imaeda Japan 26 1.4k 0.8× 1.2k 1.5× 257 0.3× 905 1.3× 656 1.0× 73 3.5k
Nagamu Inoue Japan 32 811 0.5× 1.7k 2.0× 360 0.5× 904 1.3× 1.2k 1.7× 91 3.5k

Countries citing papers authored by Shervin Rabizadeh

Since Specialization
Citations

This map shows the geographic impact of Shervin Rabizadeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shervin Rabizadeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shervin Rabizadeh more than expected).

Fields of papers citing papers by Shervin Rabizadeh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shervin Rabizadeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shervin Rabizadeh. The network helps show where Shervin Rabizadeh may publish in the future.

Co-authorship network of co-authors of Shervin Rabizadeh

This figure shows the co-authorship network connecting the top 25 collaborators of Shervin Rabizadeh. A scholar is included among the top collaborators of Shervin Rabizadeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shervin Rabizadeh. Shervin Rabizadeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roberts, Pamela R., Andrea F. Wise, Karen Zaghiyan, et al.. (2024). MULTIMODAL PREHABILITATION MAY IMPROVE SURGICAL OUTCOMES FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE. Inflammatory Bowel Diseases. 30(Supplement_1). S6–S7. 1 indexed citations
2.
Roberts, Pamela R., Andrea F. Wise, Karen Zaghiyan, et al.. (2024). MULTIMODAL PREHABILITATION MAY IMPROVE SURGICAL OUTCOMES FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE. Gastroenterology. 166(3). S8–S9. 1 indexed citations
3.
Geem, Duke, David M. Hercules, Suresh Venkateswaran, et al.. (2023). Progression of Pediatric Crohn’s Disease Is Associated With Anti–Tumor Necrosis Factor Timing and Body Mass Index Z-Score Normalization. Clinical Gastroenterology and Hepatology. 22(2). 368–376.e4. 9 indexed citations
4.
Dubinsky, Marla C., Shervin Rabizadeh, John C. Panetta, et al.. (2023). The Combination of Predictive Factors of Pharmacokinetic Origin Associates with Enhanced Disease Control during Treatment of Pediatric Crohn’s Disease with Infliximab. Pharmaceutics. 15(10). 2408–2408. 2 indexed citations
5.
Gu, Phillip, Shishir Dube, Yoojin Lee, et al.. (2023). Comparative Persistence of Non-tumor Necrosis Factor (TNF) vs. TNF Antagonists for Post-operative Prophylaxis in Crohn’s Disease (CD). Digestive Diseases and Sciences. 69(1). 235–245. 2 indexed citations
6.
Hemperly, Amy, Marla C. Dubinsky, Andrés Yarur, et al.. (2021). Noninvasive Targeted Crohn Disease Management by Combining Endoscopic Healing Index and Therapeutic Drug Monitoring. Crohn s & Colitis 360. 3(3). otab035–otab035. 1 indexed citations
7.
Rabizadeh, Shervin, et al.. (2021). DETERMINANTS OF INFLAMMATORY BOWEL DISEASE PATIENT SATISFACTION AFTER TRANSITION TO VIRTUAL VISITS. Inflammatory Bowel Diseases. 27(Supplement_1). S48–S49. 1 indexed citations
8.
Rabizadeh, Shervin, et al.. (2021). DEVELOPMENT OF A PERSONALIZED MODEL OF INTESTINAL FIBROSIS USING HUMAN INTESTINAL ORGANOIDS DERIVED FROM INDUCED PLURIPOTENT STEM CELLS. Inflammatory Bowel Diseases. 27(Supplement_1). S35–S35. 2 indexed citations
9.
Yoon, Soon Man, Talin Haritunians, Zhenqiu Liu, et al.. (2017). Colonic Phenotypes Are Associated with Poorer Response to Anti-TNF Therapies in Patients with IBD. Inflammatory Bowel Diseases. 23(8). 1382–1393. 28 indexed citations
10.
Zhu, Leilei, Gil Melmed, Xiaofei Yan, et al.. (2017). UBE2L3, ANCA, ASCA, and CBIR1 are Associated with Mechanisms of non-Response to Anti-TNF in IBD Patients with Adequate Drug Levels. Gastroenterology. 152(5). S380–S381. 2 indexed citations
11.
Zaghiyan, Karen, Gil Melmed, Eric Vasiliauskas, et al.. (2016). Outcomes with Anti-Tumour Necrosis Factor-Alpha Therapy and Serology in Patients withDenovoCrohn’s Disease After Ileal Pouch Anal Anastomosis. Journal of Crohn s and Colitis. 11(1). 77–83. 20 indexed citations
12.
Singh, Namita, Minesh Patel, Shervin Rabizadeh, & Marla C. Dubinsky. (2015). 321 Vedolizumab Use in Pediatric Patients With Inflammatory Bowel Disease. Gastroenterology. 148(4). S–72. 3 indexed citations
13.
Rabizadeh, Shervin, et al.. (2014). A 10-Year, Single Tertiary Care Center Experience on the Durability of Infliximab in Pediatric Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 20(4). 606–613. 42 indexed citations
14.
Wick, Elizabeth C., Shervin Rabizadeh, Emilia Albesiano, et al.. (2014). Stat3 Activation in Murine Colitis Induced by Enterotoxigenic Bacteroides fragilis. Inflammatory Bowel Diseases. 20(5). 821–834. 90 indexed citations
15.
Min, Steve B., Namita Singh, Cade M. Nylund, et al.. (2013). Video Capsule Endoscopy Impacts Decision Making in Pediatric IBD. Inflammatory Bowel Diseases. 19(10). 2139–2145. 38 indexed citations
16.
Goodwin, Andrew C., Christina E. DeStefano Shields, Shaoguang Wu, et al.. (2011). Polyamine catabolism contributes to enterotoxigenicBacteroides fragilis-induced colon tumorigenesis. Proceedings of the National Academy of Sciences. 108(37). 15354–15359. 463 indexed citations breakdown →
17.
Soliman, Antoine, Kathrin S. Michelsen, Hisae Karahashi, et al.. (2010). Platelet-Activating Factor Induces TLR4 Expression in Intestinal Epithelial Cells: Implication for the Pathogenesis of Necrotizing Enterocolitis. PLoS ONE. 5(10). e15044–e15044. 66 indexed citations
18.
Rhee, Ki‐Jong, Shaoguang Wu, Xinqun Wu, et al.. (2009). Induction of Persistent Colitis by a Human Commensal, EnterotoxigenicBacteroides fragilis, in Wild-Type C57BL/6 Mice. Infection and Immunity. 77(4). 1708–1718. 222 indexed citations
19.
Rabizadeh, Shervin, Ki‐Jong Rhee, Shaoguang Wu, et al.. (2007). Enterotoxigenic Bacteroides fragilis: A potential instigator of colitis. Inflammatory Bowel Diseases. 13(12). 1475–1483. 114 indexed citations
20.
Anton, Rein, Jeffrey H. Kordower, Nigel T. Maidment, et al.. (1994). Neural-Targeted Gene Therapy for Rodent and Primate Hemiparkinsonism. Experimental Neurology. 127(2). 207–218. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026